0.29Open0.50Pre Close1 Volume315 Open Interest0.50Strike Price29.00Turnover0.00%IV-1.50%PremiumOct 18, 2024Expiry Date0.30Intrinsic Value100Multiplier15DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.77Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Sangamo Therapeutics Stock Discussion
Gene Editing Therapeutics Market Report 2024, Featuring Profiles of Key Players Allogene Therapeutics, CRISPR Therapeutics, Intellia Therapeutics, Sangamo Therapeutics and Vertex Pharmaceuticals - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Gene Editi
https://www.moomoo.com/t/news/post/43596799/BYnzVJBmba
Bought big Friday, looks like I made the right call. GLTA
No comment yet